Federal Register / Vol. 62, No. 145 / Tuesday, July 29, 1997 / Notices 40537

determine whether future revisions to

the guidance document are warranted.

Dated: January 21, 1997.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 97–19821 Filed 7-28-97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–P–15A]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summaries of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

1. Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Medicare

Current Beneficiary Survey (MCBS)

Rounds: 20–32; Form No.: HCFA–P–

15A (OMB# 0938–0568); Use: The

MCBS is a continuous, multipurpose

survey of a nationally representative

sample of aged and disabled persons

enrolled in Medicare. The survey

provides a comprehensive source of

information on beneficiary

characteristics, needs, utilization, and

satisfaction with Medicare-related

activities; Frequency: Other (3 times a

year per respondent); Affected Public:

Individuals and households; Number of

Respondents: 16,000; Total Annual

Responses: 48,000; Total Annual Hours:

48,000.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, E-mail your request,

including your address and phone

number, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards Attention: John

Rudolph, Room C2–26–17, 7500

Security Boulevard, Baltimore,

Maryland 21244–1850.

Dated: July 9, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, Division of

HCFA Enterprise Standards, Health Care

Financing Administration.

[FR Doc. 97–19924 Filed 7–28–97; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meeting:

Name of SEP: Genetic Epidemiology of

Lung Cancer I and II.

Date: August 4, 1997.

Time: 11:00 a.m. to 12:30 p.m.

Place: Teleconference, National Cancer

Institute, Executive Plaza North, Room 635G,

6130, Executive Boulevard, Bethesda, MD

20892.

Contact Person: Sally A. Mulhern, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 635G, 6130 Executive Boulevard, MSC

7410, Bethesda, MD 20892–7410, Telephone:

301/496–7413.

Purpose/Agenda: To evaluate and review

grant applications.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: July 22, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–19848 Filed 7–28–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meetings:

Name of SEP: Pivotal Clinical Trials for

Chemoprevention Agent Development.

Date: August 18–19, 1997.

Time: August 18—7:00 a.m.–5:00 p.m.;

August 19—8:00 a.m.–5:00 p.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, Md 20852.

Contact Person: Ray Bramhall, PhD.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 636, 6130 Executive Boulevard, MSC

7410, Bethesda, Md 20892–7410, Telephone:

301/496–3428.

Purpose/Agenda: To evaluate and review

grant applications.

Name of SEP: Chemoprevention in

Genetically-Identified High-Risk Groups:

Interactive Research and Development

Project.

Date: August 25–26, 1997.

Time: August 25—8:30 a.m.–5:00 p.m.;

August 26—8:00 a.m.–5:00 p.m.

Place: Hyatt Regency Bethesda, 1 Bethesda

Metro Center, Bethesda, Md 20814.

Contact Person: Ray Bramhall, PhD.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 636, 6130 Executive Boulevard, MSC

7410, Bethesda, Md 20892–7410, Telephone:

301/496–3428.

Purpose/Agenda: To evaluate and review

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commerical property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,